ARS Pharma Inc - SPRY - stock price prediction, stock price target, analyst ratings from 6 analysts
ARS Pharma Inc has a share price target of US$ 27, revenue growth forecast of 90.2%, and profit growth estimate of 12.9% for FY26, based on top 6 analyst calls.